Summary & Overview

HCPCS C1788: Indwelling (Implantable) Port

HCPCS Level II code C1788 denotes an indwelling (implantable) port used for long-term central venous access. These devices are central to delivery of repeated intravenous therapies, including oncology infusions, prolonged antimicrobial regimens, and parenteral nutrition, making the code relevant across hospitals and ambulatory surgery centers nationwide. The code matters for national billing consistency and coverage decisions tied to durable implanted vascular access. Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical context and service settings associated with C1788, payer coverage patterns where available, common billing modifiers used alongside the code, and related procedural or supply codes when provided. The publication outlines benchmarks and policy considerations relevant to reimbursement and claims processing, and summarizes typical sites of service and use cases for implanted ports. Data not available in the input is clearly marked where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareC1788HCPCS Level IIimplantable portvascular accessinfusion therapyoutpatient surgeryhospital outpatientbilling

Billing Code Overview

HCPCS Level II code C1788 describes an indwelling (implantable) port, a vascular access device placed beneath the skin to provide long-term central venous access. This device is typically used for repeated administration of intravenous therapies such as chemotherapy, long-term antibiotics, or parenteral nutrition.

Service type: Insertion or implantation of an indwelling vascular port.

Typical site of service: Hospital outpatient department or ambulatory surgical center; may also be placed in an inpatient setting when clinically indicated.

Clinical & Coding Specifications

Clinical Context

A 58-year-old patient with metastatic colorectal cancer requires long-term central venous access for repeated cycles of chemotherapy. The oncology team schedules placement of an implantable port (subcutaneous infusion port with catheter) to facilitate reliable venous access, reduce peripheral IV trauma, and allow administration of vesicants, antibiotics, and parenteral nutrition as needed. The procedure is typically performed in an outpatient ambulatory surgical center or hospital interventional radiology suite under moderate sedation or monitored anesthesia care. Pre-procedure steps include verification of indication, informed consent, assessment of coagulation status, and sterile site preparation. Ultrasound guidance is commonly used to access a central vein (internal jugular or subclavian), fluoroscopy verifies catheter tip placement in the superior vena cava, and the port reservoir is seated in a subcutaneous chest wall pocket and sutured in place. Post-procedure workflow includes chest radiograph or fluoroscopic confirmation of catheter tip position and absence of pneumothorax, wound dressing, documentation of port type and serial number, patient education on port care and signs of infection, and scheduling for future access by oncology nursing for chemotherapy administration.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier/standard reporting	Use when no special reporting modifier is required for the service.
`51`	Multiple procedures	Use when the port placement is billed on the same day as additional distinct procedures and payer requires multiple-procedure reporting.
`52`	Reduced services	Use when a port implantation is partially reduced or not completed as originally planned.
`53`	Discontinued procedure	Use when implantation is started but discontinued due to an unforeseen complication.
`59`	Distinct procedural service	Use when a separate and distinct procedure is performed the same day (e.g., tunneled catheter removal) and documentation supports distinct elements.
`62`	Two surgeons	Use when two surgeons with different specialties perform separate, distinct surgical components of the port placement.
`80`	Assistant surgeon	Use when a surgical assistant participates and payer requires reporting of assistant surgeon services.
`81`	Minimum assistant surgeon	Use when a minimal assistant surgeon role is reported per payer guidance.
`82`	Assistant surgeon (when qualified resident not available)	Use when an assistant surgeon is needed and no qualified resident is available.
`91`	Repeat clinical diagnostic laboratory test	Use when the same laboratory test is repeated on the same date to confirm safety (e.g., coagulation studies) per payer rules.
`AS`	Physician assistant, nurse practitioner, or clinical nurse specialist performed services in critical access hospital	Use when an advanced practice clinician performs or assists with peri-procedural care as defined by payer.
`LT`	Left side	Use to indicate the port was implanted on the left side of the chest/left subclavian/internal jugular approach.
`RT`	Right side	Use to indicate the port was implanted on the right side of the chest/right subclavian/internal jugular approach.
`59`	Distinct procedural service	Use to indicate a separate service from other procedures performed on the same date (included above for emphasis).

Taxonomy Code	Specialty	Notes
`2084P0800X`	Interventional Radiology	Frequently places implantable ports using image guidance.
`2086S0125X`	Surgical Oncology	Performs port placement as part of cancer therapy management.
`207P00000X`	General Surgery	Commonly performs subcutaneous port implantation in operative settings.
`363L00000X`	Vascular Surgery	Performs central venous access and port implantation for complex vascular anatomy.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`C78.7`	Secondary malignant neoplasm of liver and intrahepatic bile duct	Indicates metastatic disease requiring long-term central venous access for systemic therapy.
`C18.9`	Malignant neoplasm of colon, unspecified	Colorectal cancer commonly requires systemic chemotherapy administered via an implantable port.
`Z45.2`	Encounter for adjustment and management of vascular access device	Used for subsequent management visits and programming related to implanted ports.
`Z96.1`	Presence of vascular catheter, not elsewhere classified	Used to document the presence of an indwelling vascular device such as a port for future care encounters.
`T82.7XXA`	Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounter	Applicable for initial encounter if port-related infection occurs and requires evaluation or removal.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`36561`	Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump, age 5 years or older	Alternative long-term central venous access option; may be chosen instead of an implantable port depending on clinical needs.
`38330`	Insertion of a totally implantable central venous access device (e.g., Port-A-Cath), with subcutaneous reservoir, age 5 years or older	Directly corresponds to the surgical insertion of an implantable port; often reported for the operative procedure when CPT is used.
`36556`	Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older	Often used for emergent short-term access prior to placement of a permanent port.
`76937`	Ultrasound guidance for vascular access requiring imaging and interpretation, first vessel	Commonly billed when ultrasound guidance is used to access the internal jugular or other central vein during port placement.
`77012`	Fluoroscopic guidance for needle localization and radiological supervision and interpretation	Billed when fluoroscopy is used to confirm catheter tip position during port insertion.